Quarterly Period Covered: Q2 2026 (six months ended June 30, 2026) with comparative data for Q2 2025 and first half of 2025 Financial Statements Included: Unaudited condensed consolidated balance sheets as of June 30, 2026 and December 31, 2025; statements of operations for six-month and three-month periods; statements of stockholders' equity; and cash flow statements Company Overview: DENTSPLY…

Our analysis rates this filing NEUTRAL. DENTSPLY SIRONA presents a stable risk profile with a MODERATE concern level of 4.2/10, reflecting a balanced and neutral assessment. The company demonstrates normal operational functioning with no material negative developments, legal issues, regulatory…

Concern level: ELEVATED (4.2/10). Key factors: Derivative financial instruments exposure to foreign exchange and interest rate volatility; Multinational operations create currency translation risks; Limited visibility into current period financial performance and operational metrics.

Notable risk changes: Filing contains primarily structural XBRL data and financial statement contexts with minimal substantive risk narrative disclosed in this excerpt; No material negative events, litigation, regulatory actions, or operational disruptions evident in available filing content; Company maintains normal business segment reporting across Connected Technology Solutions, Essential Dental Solutions, and…

The model predicts XRAY will underperform the S&P 500 by about 0.0% over 30 days (model confidence 50%). This is model analysis for research, not investment advice.